Musculus orbicularis oris
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
27.09.2019
Interview with Rebecca Naumann: Cryolipolysis devices in comparison
When treating fat cells with cold it depends on the technique: The two leading suppliers in the German-speaking countries rely on certified medical technology. But what are the differences between […]
31.05.2018
Cutera Announces Opening of New Office and Training Center in Madrid
CUTERA, INC., (Nasdaq:CUTR) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announces the opening of its new office and training […]